J D Hardcastle

2.7k total citations · 1 hit paper
37 papers, 1.9k citations indexed

About

J D Hardcastle is a scholar working on Oncology, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, J D Hardcastle has authored 37 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 12 papers in Surgery and 9 papers in Pathology and Forensic Medicine. Recurrent topics in J D Hardcastle's work include Colorectal Cancer Screening and Detection (11 papers), Genetic factors in colorectal cancer (8 papers) and Gastric Cancer Management and Outcomes (5 papers). J D Hardcastle is often cited by papers focused on Colorectal Cancer Screening and Detection (11 papers), Genetic factors in colorectal cancer (8 papers) and Gastric Cancer Management and Outcomes (5 papers). J D Hardcastle collaborates with scholars based in United Kingdom, United States and Italy. J D Hardcastle's co-authors include Gordon Gilbert, A G Parks, J H Scholefield, C M Mangham, Sue Moss, D K Whynes, J Chamberlain, H J R Bussey, P A Farrands and S Moss and has published in prestigious journals such as Gastroenterology, Gut and British Journal of Cancer.

In The Last Decade

J D Hardcastle

36 papers receiving 1.8k citations

Hit Papers

A classification of fistu... 1976 2026 1992 2009 1976 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J D Hardcastle United Kingdom 17 1.3k 806 520 308 250 37 1.9k
C G Marks United Kingdom 21 1.1k 0.8× 983 1.2× 118 0.2× 240 0.8× 190 0.8× 50 1.5k
Frank L. Weakley United States 28 1.5k 1.1× 839 1.0× 338 0.7× 319 1.0× 344 1.4× 59 2.2k
N. J. Mortensen United Kingdom 29 1.7k 1.3× 1.4k 1.8× 268 0.5× 323 1.0× 142 0.6× 64 2.4k
A Tocchi Italy 25 1.2k 0.9× 635 0.8× 72 0.1× 774 2.5× 138 0.6× 90 1.6k
Édouard Pertuiset France 22 475 0.4× 570 0.7× 488 0.9× 458 1.5× 166 0.7× 59 2.3k
Herbert J. Buchsbaum United States 23 881 0.7× 384 0.5× 60 0.1× 236 0.8× 134 0.5× 69 1.8k
Joel A. Roth United States 16 302 0.2× 302 0.4× 276 0.5× 381 1.2× 191 0.8× 33 1.0k
David Atallah Lebanon 23 727 0.6× 342 0.4× 125 0.2× 157 0.5× 167 0.7× 109 1.9k
Gil Dubernard France 30 938 0.7× 191 0.2× 230 0.4× 165 0.5× 84 0.3× 101 3.1k
C. Thomas Kisker United States 19 286 0.2× 210 0.3× 162 0.3× 462 1.5× 89 0.4× 56 1.6k

Countries citing papers authored by J D Hardcastle

Since Specialization
Citations

This map shows the geographic impact of J D Hardcastle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J D Hardcastle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J D Hardcastle more than expected).

Fields of papers citing papers by J D Hardcastle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J D Hardcastle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J D Hardcastle. The network helps show where J D Hardcastle may publish in the future.

Co-authorship network of co-authors of J D Hardcastle

This figure shows the co-authorship network connecting the top 25 collaborators of J D Hardcastle. A scholar is included among the top collaborators of J D Hardcastle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J D Hardcastle. J D Hardcastle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Scholefield, J H, Sue Moss, C M Mangham, D K Whynes, & J D Hardcastle. (2011). Nottingham trial of faecal occult blood testing for colorectal cancer: a 20-year follow-up. Gut. 61(7). 1036–1040. 212 indexed citations
2.
Robinson, M.H., J D Hardcastle, Sue Moss, et al.. (1999). The risks of screening: data from the Nottingham randomised controlled trial of faecal occult blood screening for colorectal cancer. Gut. 45(4). 588–592. 81 indexed citations
3.
Scholefield, J H, Michael H. Robinson, C M Mangham, & J D Hardcastle. (1998). Screening for colorectal cancer reduces emergency admissions. European Journal of Surgical Oncology. 24(1). 47–50. 47 indexed citations
4.
5.
Faivre, J, J P Bader, Lucio Bertario, et al.. (1995). Mass screening for colorectal cancer: Statement of the European Group for Colorectal Cancer Screening. European Journal of Cancer Prevention. 4(5). 437–439. 4 indexed citations
6.
Rooney, P. S., et al.. (1994). DNA content of rectal mucosa and rectal mucosal proliferation in individuals at high risk of colorectal cancer. European Journal of Cancer Prevention. 3(1). 57–62. 2 indexed citations
7.
Hardcastle, J D, et al.. (1993). Screening and the costs of treating colorectal cancer. British Journal of Cancer. 68(5). 965–968. 19 indexed citations
8.
Ballantyne, K C, RM Charnley, Alan C. Perkins, et al.. (1990). Hepatic perfusion index in the diagnosis of overt metastatic colorectal cancer. Nuclear Medicine Communications. 11(1). 23–28. 20 indexed citations
9.
Armitage, N C, et al.. (1990). The influence of tumour cell DNA content on survival in colorectal cancer: a detailed analysis. British Journal of Cancer. 62(5). 852–856. 31 indexed citations
10.
Robertson, C S, C.D.M. Griffith, Mark A. Atkinson, & J D Hardcastle. (1988). Pseudoachalasia of the Cardia: A Review. Journal of the Royal Society of Medicine. 81(7). 399–402. 21 indexed citations
11.
Durrant, LG, et al.. (1987). Sensitivity of newly established colorectal cell lines to cytotoxic drugs and monoclonal antibody drug conjugates. British Journal of Cancer. 56(6). 722–726. 13 indexed citations
12.
Pimm, M. V., N C Armitage, K C Ballantyne, et al.. (1987). Imaging of primary and metastatic colorectal carcinoma with monoclonal antibody 791T/36 and the therapeutic potential of antibody-drug conjugates.. PubMed. 1. 249–62. 5 indexed citations
13.
Durrant, LG, R. A. Robins, Alan C. Perkins, et al.. (1986). Antigenicity of newly established colorectal carcinoma cell lines. British Journal of Cancer. 53(1). 37–45. 26 indexed citations
14.
Armitage, N C & J D Hardcastle. (1984). Screening for asymptomatic bowel cancer in general practice. BMJ. 288(6415). 488.1–488. 2 indexed citations
15.
Stower, Michael J., J D Hardcastle, & J B Bourke. (1984). Surgical emergencies and manpower.. PubMed. 66(2). 117–450. 16 indexed citations
16.
Farrands, P A, J D Hardcastle, J Chamberlain, & S Moss. (1984). Factors affecting compliance with screening for colorectal cancer. Journal of Public Health. 6(1). 12–9. 96 indexed citations
17.
Hardcastle, J D, et al.. (1983). Endoscopic review ofpatients whohavehadgastric surgery. 1 indexed citations
18.
Ritchie, H D, et al.. (1971). Isolated organ perfusion for physiologic studies. Digestive Diseases and Sciences. 16(1). 81–87. 5 indexed citations
19.
Hardcastle, J D, et al.. (1969). Localized bruit in carcinoma of the pancreas. British journal of surgery. 56(1). 79–79. 1 indexed citations
20.
Hardcastle, J D & H J R Bussey. (1968). Results of surgical treatment of squamous cell carcinoma of the anal canal and anal margin seen at St. Mark's Hospital 1928-66.. PubMed. 61(6). 629–30. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026